Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure

Journal of the American College of Cardiology

Volumn 40, Issue 10, 2002, Pages 1801-1808

  Kearney, Mark T ^a,n   Fox, Keith A A ^b   Lee, Amanda J ^c   Prescott, Robin J ^c   Shah, Ajay M ^a   Batin, Philip D ^e   Baig, Wazir ^f   Lindsay, Stephen ^g   Callahan, Timothy S ^h   Shell, William E ⁱ   Eckberg, Dwain L ^j   Zaman, Azfar G ^k   Williams, Simon ^l   Neilson, James M M ^d   Nolan, James ^m  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Department of Cardiology ^*  (United Kingdom)

^c Medical Statistics Unit   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e Pontefract and Wakefield Hospitals   (United Kingdom)

^f DONCASTER ROYAL INFIRMARY   (United Kingdom)

^g BRADFORD ROYAL INFIRMARY   (United Kingdom)

^h Phase5 Sciences   (United States)

ⁱ NETT Foundation   (United States)

^j VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k FREEMAN HOSPITAL   (United Kingdom)

^l ARROWE PARK HOSPITAL   (United Kingdom)

^m North Staffordshire Maternity Unit   (United Kingdom)

ⁿ KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; SODIUM ION;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RR INTERVAL; SODIUM BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHRONIC DISEASE; COHORT STUDIES; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME;

EID: 0037145913     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02490-7     Document Type: Article

References (36)

1. Ghali JK, Cooper R, Ford E. Trends in hospitalization for heart failure in the United States, 1973-1986: Evidence for increasing population prevalence. Arch Intern Med 1990;150:769-73.
2. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
3. The Captopril-Digoxin Multicentre Research Group. Comparative effects of therapy with captopril and digoxin in mild to moderate heart failure. JAMA 1988;259:539-44.
4. Mann DL. Mechanisms and models in heart failure: A combinatorial approach. Circulation 1999;100:999-1008.
5. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 1999;353:9-13.
6. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1992;327:685-91.
7. Gradman A, Deedwania P, Cody R, et al. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol 1989;14:564-70.
8. Singh SN, Fisher SG, Carson PE, et al. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. J Am Coll Cardiol 1998;32:942-7.
9. Teerlink JR, Jalaluddin M, Anderson S, et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. Circulation 2000;101:40-6.
10. Eichorn EJ. Prognosis determination in heart failure. Am J. Med 2001;Suppl 110:14s-36s.
11. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17.
12. Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure. Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart). Circulation 1998;98:1510-6.
13. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-65.
14. Saul JP, Arai Y, Berger RD, et al. Assessment of autonomic regulation in chronic congestive heart failure by spectral heart rate analysis. Am J Cardiol 1988;61:1292-9.
15. Pomeranz B, Macaulay RJB, Caudill MA, et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985;248:H151-3.
16. Coresh J, Astor BC, McQuillan G, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002;39:920-9.
17. Leimbach WN Jr., Wallin BG, Victor RG, et al. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986;73:913-9.
18. Porter TR, Eckberg DL, Fritsch JM, et al. Autonomic pathophysiology in heart failure patients: Sympathetic-cholinergic interrelations. J Clin Invest 1990;85:1362-71.
19. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, et al. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 1997;95:169-75.
20. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23.
21. Dzau VJ, Colucci WS, Hollenberg NK, et al. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 1981;20:S203-309.
22. Taylor JA, Myers CW, Halliwill JR, et al. Sympathetic restraint of respiratory sinus arrhythmia: Implications for assessment of vagalcardiac tone in humans. Am J Physiol 2001;280:H2804-14.
23. Taylor JA, Cart DL, Myers CW, et al. Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation 1998;98:547-55.
24. Nolan J, Flapan AD, Capewell S, Macdonald T, Neilson JMM, Ewing DJ. Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. Br Heart J 1992;27:642-9.
25. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 1971;285:877-83.
26. Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 1992;262:E763-78.
27. Bristow MR. The adrenergic nervous system in heart failure. N Engl J Med 1984;311:850-1.
28. Tan LB, Jalil JE, Pick R, Janicki JS, Weber KT. Cardiac myocyte necrosis induced by angiotensin II. Circ Res 1991;69:1185-95.
29. Cohn JN, Ferrari R, Sharpe N, on behalf of an International Forum on Cardiac Remodelling. Cardiac remodelling - Concepts and clinical implications: A consensus paper from an international forum on cardiac remodelling. J Am Coll Cardiol 2000;35:569-82.
30. Horner SM, Murphy CF, Coen B, et al. Contribution to heart rate variability by mechanoelectrical feedback. Stretch of the sinus node reduces heart rate variability. Circulation 1996;94:1726-67.
31. Flapan AD, Nolan J, Neilson JMM, et al. Effect of captopril on cardiac parasympathetic activity in chronic cardiac failure secondary to coronary artery disease. Am J Cardiol 1992;69:532-5.
32. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting enzyme inhibition in patients with severe chronic heart failure. Circulation 1986;73:257-67.
33. Aaronson KD, Schwartz S, Chen T-M, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997;95:2660-7.
34. Hillege HL, Girbes ARJ, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102:203-10.
35. Dries DL, Exner DV, Domanski MJ, et al. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000;35:681-9.
36. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction. J Am Coll Cardiol 1999;33:1948-55.